MIRA PHARMACEUTICALS, INC.（MIRA）内部人交易：高管与董事近期交易
过去 18 个月，共有 2 位内部人为 MIRA PHARMACEUTICALS, INC.（MIRA）报告了 8 笔 Form 4 交易（最近一笔 2026-02-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-17 | Aminov Erez | CEO and Chairman | 买入 | 62,500 | $90,625 |
| 2026-02-17 | Aminov Erez | CEO and Chairman | 买入 | 62,500 | $90,625 |
| 2026-02-17 | Aminov Erez | CEO and Chairman | 买入 | 234,595 | $272,130 |
| 2026-02-17 | Aminov Erez | CEO and Chairman | 买入 | 379,000 | $318,360 |
| 2026-02-17 | Aminov Erez | CEO and Chairman | 卖出 | 613,595 | $1.3M |
| 2025-10-03 | Shekhat Denil Nanji | 董事 | 买入 | 22,378 | $30,210 |
| 2025-10-03 | Aminov Erez | Chief Executive Officer | 买入 | 2.7M | $0 |
| 2025-09-03 | Aminov Erez | Chief Executive Officer | 买入 | 62,500 | $85,625 |
来源：SEC Form 4 申报文件 · 截至 2026-02-17